Agilent/$A
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Agilent
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Ticker
$A
Sector
Primary listing
NYSE
Employees
18,000
Headquarters
Website
Agilent Metrics
BasicAdvanced
$41B
34.05
$4.28
1.26
$0.99
0.68%
Price and volume
Market cap
$41B
Beta
1.26
52-week high
$153.84
52-week low
$96.43
Average daily volume
1.7M
Dividend rate
$0.99
Financial strength
Current ratio
2.248
Quick ratio
1.542
Long term debt to equity
55.495
Total debt to equity
56.421
Dividend payout ratio (TTM)
22.95%
Interest coverage (TTM)
13.26%
Profitability
EBITDA (TTM)
1,838
Gross margin (TTM)
52.58%
Net profit margin (TTM)
17.97%
Operating margin (TTM)
22.86%
Effective tax rate (TTM)
12.48%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
8.07%
Return on equity (TTM)
19.88%
Valuation
Price to earnings (TTM)
34.054
Price to revenue (TTM)
6.119
Price to book
6.49
Price to tangible book (TTM)
29.01
Price to free cash flow (TTM)
38.177
Free cash flow yield (TTM)
2.62%
Free cash flow per share (TTM)
3.821
Dividend yield (TTM)
0.68%
Forward dividend yield
0.68%
Growth
Revenue change (TTM)
4.48%
Earnings per share change (TTM)
-11.02%
3-year revenue growth (CAGR)
0.64%
10-year revenue growth (CAGR)
5.31%
3-year earnings per share growth (CAGR)
-0.79%
10-year earnings per share growth (CAGR)
15.82%
3-year dividend per share growth (CAGR)
5.95%
10-year dividend per share growth (CAGR)
8.54%
What the Analysts think about Agilent
Analyst ratings (Buy, Hold, Sell) for Agilent stock.
Bulls say / Bears say
Revenue for Q3 FY25 rose 10.1% year-over-year to $1.74 billion, surpassing guidance and prompting Agilent to raise its full-year revenue outlook to $6.91–6.93 billion (+6.2% to +6.5%), underscoring robust demand across segments and geographies (Agilent)
GAAP EPS for Q3 FY25 increased 22% year-over-year to $1.18, demonstrating strong profitability improvements from the Ignite transformation despite a challenging macro backdrop (Agilent)
The Life Sciences and Diagnostics Markets Group achieved 14% reported revenue growth in Q3 FY25 to $670 million, highlighting sustained strength in high-margin diagnostics and genomics end markets (Agilent)
GAAP net income in Q2 FY25 fell 29% year-over-year to $215 million (EPS $0.75), reflecting volatility from transformation investments and signaling potential earnings swings ahead (Agilent)
Agilent noted a “full quarter of the dynamic tariff environment” in Q3, indicating persistent input-cost pressures from trade tensions that may constrain margins if not resolved (Agilent)
Chinese pharma R&D firms are increasingly sourcing reagents from domestic suppliers to cut costs and delivery times, threatening to erode Agilent’s CrossLab consumables revenues in its key market (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2025.
Agilent Financial Performance
Revenues and expenses
Agilent Earnings Performance
Company profitability
Agilent News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Agilent stock?
Agilent (A) has a market cap of $41B as of October 23, 2025.
What is the P/E ratio for Agilent stock?
The price to earnings (P/E) ratio for Agilent (A) stock is 34.05 as of October 23, 2025.
Does Agilent stock pay dividends?
Yes, the Agilent (A) stock pays dividends to shareholders. As of October 23, 2025, the dividend rate is $0.992 and the yield is 0.68%. Agilent has a payout ratio of 22.95% on a trailing twelve-month basis.
When is the next Agilent dividend payment date?
The next Agilent (A) dividend payment date is unconfirmed.
What is the beta indicator for Agilent?
Agilent (A) has a beta rating of 1.26. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.